Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer

Comprehensive characterization of the genomic landscape of epidermal growth factor receptor (EGFR)-mutated lung cancers have identified patterns of secondary mutations beyond the primary oncogenic EGFR mutation. These include concurrent pathogenic alterations affecting p53 (60–65%), RTKs (5–10%), PI...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Thorac Dis
Huvudupphovsmän: Gini, Beatrice, Thomas, Nicholas, Blakely, Collin M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2020
Ämnen:
Review Article on Mechanisms of Resistance to EGFR-targeted Therapy
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330397/
https://ncbi.nlm.nih.gov/pubmed/32642201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.03.78
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk